Gamma Pharmaceuticals, Inc. Announces Key

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco

Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing

Date : 03/07/2012 @ 7:00AM
Source : PR Newswire
Stock : Gamma Pharmaceuticals (PL) (GMPM)
Quote : 0.08  0.0 (0.00%) @ 9:31AM

Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing

Gamma Pharmaceuticals (PL) (USOTC:GMPM)
Intraday Stock Chart

Today : Wednesday 7 March 2012

Click Here for more Gamma Pharmaceuticals (PL) Charts.

Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK) announced today, that Bruce Renick , a senior industry insider, has agreed to join Gamma, initially on the Board of Advisors, later as fulltime Executive Vice President of Sales, once resources permit.  Bruce Renick was most recently the Executive Vice President of Global Sales and Marketing for TwinLab, one of the world's largest vitamin and nutraceutical companies.  At TwinLab, Bruce launched multiple product lines and line extensions and increased margins by revenue stream across product categories. 

Bruce is assisting management to develop and later to drive a more comprehensive sales plan, creating a timeline for product launches and growing the internal functions to make Gamma Pharmaceuticals an industry leader of cutting-edge delivery system technologies in the supplement category. 

Gamma's President, Joe Cunningham commented, "We are happy that Bruce has agreed to join Gamma.  Last autumn, we changed management positions to put more focus on making sales.  If we were missing one person in our management team, it was a true industry sales professional, an experienced insider with retail contacts who can close a sale and execute.  Bruce is that guy." 

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc., ( www.gammapharma.com ) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally.  Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States.   Branded nutritional supplements are sold under the trademarks Brilliant Choice™ nutritional supplements featuring the call to action "You've made a brilliant choice for your nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and, Gamma Energy Products™ a high performance supplement featuring the call to action, "Get Your Gamma On."  Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market.  A series of innovative marketing programs support Gamma's product sales and retail partners.  

At present Gamma manufactures in North America , and distributes in the United States. Gamma's products utilize proprietary "Gel Delivery Technology®", to create innovative gel product forms that give consumers a more pleasant experience.  Gel Delivery Technology® characteristics include rapid absorption, convenience and great taste.  Market categories Gamma targets are growing as rapidly as 60% per year.  Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well-being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers.  At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China .

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Gamma Pharmaceuticals, Inc. Joe Cunningham , President ( jcunningham@gammapharma.com )Direct:  (651) 204 2048

SOURCE Gamma Pharmaceuticals, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska Air Group's Q3: Facing Headwinds and Strategies

Updated Category News Views 10

Weathering the Q3 Storm Alaska Air Group's third quarter results are in the bag, and let me tell ya, it's a mixed bag of sour lemons and hopeful limes. Reporting a net loss of $147 million or ($1.32) per share ain't the kind of results that plaster smiles on investors' faces. But hey, it's a volatile sector if there ever was one, especially with fuel costs ballooning to a...

Continue Reading
University Highlights Scholars' Impact on Leadership

Updated Category News Views 10

Navigating the Frontier of Academic Research There's a certain grit to diving headfirst into academia's tricky landscapes, and the University of Phoenix is throwing its cap in the ring with their inaugural President's Award. It's all happening at this virtual jamboree they call the Knowledge Without Boundaries Summit on October 22–23, 2026. They're spotlighting the...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 0

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
India's Bharat RE 2026 Amidst Global Energy Stakes

Updated Category News Views 3

India's Ambitious Energy Vision Diving right into it, India's ready to slap its mighty stamp on the global clean energy landscape. This grand affair, Bharat Renewable Energy Summit & Expo 2026, is calling in the big wigs from over 130 countries to New Delhi. It's not a casual gathering either—it's a serious play to crank up investment and tech alliances in renewable...

Continue Reading
Valmet Fuels Century Sunshine's Pulp Revolution

Updated Category News Views 4

Valmet's Bold Move in China's Pulp Industry Alright, let's dive deep into this pulp mill saga. Valmet isn't some novice in the industrial playing field, and their latest venture is a testament to that. They've clinched a hefty deal exceeding EUR 100 million to outfit Century Sunshine's Rizhao pulp mill in Shandong. This isn't just some small-time endeavor; it's a...

Continue Reading
Ellevio Bolsters Stockholm Grid with SEK 1B NIB Loan

Updated Category News Views 6

In a move that packs plenty of juice for Stockholm's energy needs, Ellevio has shaken hands with the Nordic Investment Bank (NIB) in a hefty SEK 1 billion loan agreement. This isn’t just some pocket change—this financing is a ticket to revamping and beefing up the Beckomberga substation, a project hailed for fortifying the regional electricity grid in the Swedish...

Continue Reading
NEXT Properties' Exchange Offer Sees Strong Participation

Updated Category News Views 7

NEXT Properties Makes Bold Moves with Exchange Offers NEXT Properties has pulled the trigger on a massive swap of its notes, and it's a tale investors should tune into. They're swapping out their old notes like a veteran trader ditching penny stocks for blue chips. It’s an intriguing maneuver—risk-laden yet foreboding to anyone who knows the game. Breaking Down the...

Continue Reading
Orical's Big Win in Regulatory Reporting at US Awards

Updated Category News Views 0

Orical Takes Home Prestigious Honor In the world of hedge funds, getting things straight with the regulators is as crucial as breathing. So, when Orical LLC snagged the "Regulatory Reporting Solution of the Year" at the Hedgeweek® US Awards 2026, it wasn't just a pat on the back. It screamed, "We've nailed this!" For a sector where compliance can feel like stepping...

Continue Reading
DICK'S Sporting Goods Faces Legal Challenges in Securities Suit

Updated Category News Views 5

Trouble Brewing at DICK'S Sporting Goods Wall Street's not only about the wins. There are moments when the market throws a curveball, and right now, DICK'S Sporting Goods is facing a fast one. DJS Law Group just laid out a class action lawsuit accusing them of bending the securities law rules. It ain't pretty when a company gets tangled up in legal battles, but it's...

Continue Reading
Ballard Pushes Hydrogen-Powered Events to New Heights

Updated Category News Views 1

Hydrogen Power Takes Center Stage Dive into the evolving world of event energy, and you'll find hydrogen right in the thick of things. This summer, Ballard and newly acquired GeoPura made a splash by marrying hydrogen power with live entertainment, thanks to fuel cells that kept the lights on and the amps buzzing without spewing pollutants. Cultural and Sporting Arenas...

Continue Reading

Top 5 Most Recently Viewed Articles

Array's Q2 2026 Earnings: Revenue Boom or Blip?

Updated Category News Views 12

Impressive Revenue Leap Leaves Room for Questions Array Digital Infrastructure, Inc. (NYSE:AD) has reported a surprising jolt in revenue for Q2 2026 that likely had some analysts spilling their morning coffee. Jumping from $28.5 million last year to $54.1 million this quarter, it seems the company’s strategy of optimizing operations and selling off spectrum is paying...

Continue Reading
Cullinan Therapeutics Shares Promising Zipalertinib Data Updates

Updated Category News Views 82

New Efficacy Data on Zipalertinib for Lung Cancer Cullinan Therapeutics, Inc. (NASDAQ: CGEM), headquartered in Cambridge, recently presented compelling new data highlighting the effectiveness of zipalertinib in patients suffering from non-small cell lung cancer (NSCLC) with specific mutations known as epidermal growth factor receptor (EGFR) exon 20 insertions. This...

Continue Reading
Deana Haggag: A New Chapter in Arts Leadership at Mellon

Updated Category News Views 427

Deana Haggag Takes Charge at the Mellon Foundation The Mellon Foundation is embarking on an exciting new era in arts and culture leadership with the appointment of Deana Haggag as the Program Director, effective January 1, 2025. This transition follows the esteemed leadership of Emil J. Kang, providing Haggag with the opportunity to further cultivate the Foundation’s...

Continue Reading
Superior HealthPlan and Centene Foundation Invest $400k to Combat Food Insecurity

Updated Category News Views 185

Superior HealthPlan and Centene Foundation's Investment in Texas Investment strengthens community food resources for families struggling to access healthy meals Recently, Superior HealthPlan and Centene Foundation announced a notable $400,000 investment aimed at addressing food insecurity in Texas. This strategic initiative comes at a time when many families face...

Continue Reading
Centerra Gold’s Latest Dividend Announcement and Company Insights

Updated Category News Views 188

Centerra Gold Declares Quarterly Dividend Centerra Gold Inc. has recently made headlines by announcing a quarterly dividend of C$0.07 per common share, a decision approved by its Board of Directors. This dividend translates to approximately C$14.3 million, or US$10.5 million, indicating the company's robust financial health. The payout is set for September 4, on shares...

Continue Reading